nicabate p nicotine 21mg/24 hours transdermal drug delivery system sachet
haleon australia pty ltd - nicotine, quantity: 114 mg (equivalent: nicotine, qty 21 mg/24 h) - drug delivery system, transdermal - excipient ingredients: ethylene/vinyl acetate copolymer; polyethylene; ethylene dioleamide; polyisobutylene; titanium dioxide; ethyl acetate; ethanol; isopropyl alcohol; iron oxide yellow; methyl hydrogenated rosinate; potable water; propan-1-ol; pyroxylin; glycerol/diethylene glycol ester of fumaric acid modified rosin; c18 unsaturated fatty acid dimer, tall oil fatty acid, ethylenediamine polymer; pigment violet 19; carbon black - for the treatment of nicotine dependence as an aid to smoking cessation. nicabate p patches may also be used by people who smoke 15 or more cigarettes per day for two weeks prior to quitting smoking.
nicabate clear patch nicotine 21 mg/24 hours transdermal drug delivery system sachet
haleon australia pty ltd - nicotine, quantity: 114 mg (equivalent: nicotine, qty 21 mg/24 h) - drug delivery system, transdermal - excipient ingredients: polyethylene; ethylene dioleamide; ethylene/vinyl acetate copolymer; polyisobutylene; titanium dioxide; ethyl acetate; ethanol; isopropyl alcohol; methoxyisopropanol; ethylcellulose; pyroxylin - for the treatment of nicotine dependence as an aid to smoking cessation.
nicabate clear patch nicotine 14mg/24 hours transdermal drug delivery system sachet
haleon australia pty ltd - nicotine, quantity: 78 mg (equivalent: nicotine, qty 14 mg/24 h) - drug delivery system, transdermal - excipient ingredients: ethylene dioleamide; polyethylene; ethylene/vinyl acetate copolymer; polyisobutylene; titanium dioxide; ethyl acetate; ethanol; isopropyl alcohol; methoxyisopropanol; ethylcellulose; pyroxylin - for the treatment of nicotine dependence as an aid to smoking cessation.
nicabate clear patch nicotine 7mg/24 hours transdermal drug delivery system sachet
haleon australia pty ltd - nicotine, quantity: 36 mg (equivalent: nicotine, qty 7 mg/24 h) - drug delivery system, transdermal - excipient ingredients: ethylene dioleamide; polyisobutylene; ethylene/vinyl acetate copolymer; polyethylene; titanium dioxide; ethyl acetate; ethanol; isopropyl alcohol; methoxyisopropanol; ethylcellulose; pyroxylin - for the treatment of nicotine dependence as an aid to smoking cessation.
nobligan retard 200 mg retardtabletten
nobligan retard 150 mg retardtabletten
nobligan retard 100 mg retardtabletten
tramal retard 200 mg retardtabletten
tramal retard 150 mg retardtabletten
tramal retard 100 mg retardtabletten